[Federal Register Volume 62, Number 73 (Wednesday, April 16, 1997)]
[Notices]
[Pages 18631-18632]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-9733]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Office of the Secretary
Findings of Scientific Misconduct
AGENCY: Office of the Secretary, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: Notice is hereby given that the Office of Research Integrity
(ORI) has made a final finding of scientific misconduct in the
following case:
Manoj Misra, Ph.D., Dartmouth College: Based upon the Office of
Research Integrity's (ORI) review of a report forwarded to ORI by
Dartmouth
[[Page 18632]]
College, Dr. Misra's admission of certain facts in that report, and
ORI's own analysis, ORI found that Dr. Misra, a former postdoctoral
research associate, Department of Chemistry, Dartmouth College, engaged
in scientific misconduct by intentionally altering laboratory notebook
data entries for research supported by a grant from the National
Institute of Environmental Health Sciences (NIEHS), National Institutes
of Health (NIH).
Specifically, Dr. Misra altered laboratory notebook data entries in
two instances in an effort to conceal prior manipulations of that data
without disclosure or explanation to the principal investigator or
anyone else. The experiment at issue involved an assay of the chemical
activity of a carcinogen, and Dr. Misra's change in the readings of the
``control'' experiment, in which no carcinogen was present, changed the
results.
Dr. Misra has accepted the ORI finding and has entered into a
Voluntary Exclusion Agreement with ORI in which he has voluntarily
agreed, for the three (3) year period beginning April 7, 1997:
(1) To exclude himself from serving in any advisory capacity to the
Public Health Service (PHS), including but not limited to service on
any PHS advisory committee, board, and/or peer review committee, or as
a consultant; and
(2) That any institution that submits an application for PHS
support for a research project on which Dr. Misra's participation is
proposed or which uses him in any capacity on PHS supported research
must concurrently submit a plan for supervision of his duties. The
supervisory plan must be designed to ensure the scientific integrity of
Dr. Misra's research contribution. The institution must submit a copy
of the supervisory plan to ORI.
No scientific publications were required to be corrected as part of
this Agreement.
FOR FURTHER INFORMATION CONTACT: Acting Director, Division of Research
Investigations, Office of Research Integrity, 5515 Security Lane, Suite
700, Rockville, MD 20852, (301) 443-5330.
Chris B. Pascal,
Acting Director, Office of Research Integrity.
[FR Doc. 97-9733 Filed 4-15-97; 8:45 am]
BILLING CODE 4160-17-P
